Building better tiny kidneys to test drugs and help people avoid dialysis
February 15, 2018
USC stem cell scientists investigate mouse and human kidneys to hasten new remedies for renal disease.
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.
“Stem-cell based technologies hold great promise for developing kidney replacement and regeneration therapies,” said Nils Lindstrom, first author of three new studies and a research associate in Stem Cell Biology and Regenerative Medicine at the Keck School of Medicine of USC. “Getting there requires detailed knowledge of how kidneys normally form so the process can be replicated in cell cultures in the lab. Our data will help us and other scientists improve current techniques to make better tiny functional kidneys.”
Over the past four years, USC Stem Cell researchers and USC Viterbi School of Engineering computer scientists have documented the molecular, cellular and genetic similarities and differences between human and mouse kidney formation so they can find treatments for kidney disease, which affects about 30 million Americans or 15 percent of U.S. adults.
The three-study series, published on Feb. 15 in the Journal of the American Society of Nephrology, provides the first cellular and molecular characterization of how the human kidney develops in a mother’s womb, said Andrew McMahon, study senior author and W.M. Keck Provost Professor of Stem Cell Biology and Regenerative Medicine and Biological Sciences at the Keck School of Medicine.
Kidney research has been a focus of the McMahon Lab for the past quarter century.
“Our research bridges a critical gap between animal models and human applications,” McMahon said. “The data we collected and analyzed creates a knowledge-base that will accelerate stem cell-based technologies to produce mini-kidneys that accurately represent human kidneys for biomedical screening and replacement therapies.”
The new, open-source data, available at www.gudmap.org, provides the first systematic, high-resolution atlas or databank for human kidney genesis.
How human and mouse kidneys are similar
The smallest functional unit that helps remove blood waste from the body are nephrons. Nephrons are formed in the human kidney only during fetal life, before the stem cells that generate them are exhausted.
USC Stem Cell researchers analyzed the developmental differences in scale, timing and basic structure between human and mouse kidneys. They gained insight into the regulatory processes that maintain, expand and turn kidney stem cells into mature, functional kidney structures by examining human kidneys at different stages of development and juxtaposing their observations with mouse kidneys.
Researchers compared 26 human kidney “anchor genes” with their mouse equivalents. Kidney anchor genes are required for organ development. Only three genes (11 percent) have comparable expression between mouse and human kidneys: SLC22A6, ENTPD5 and UMOD.
“If the goal is to treat human kidney disease, clearly, it’s better to focus on genes that are also active in human kidneys,” McMahon said.
Intractable problems require multidisciplinary collaboration
The median wait time for a kidney transplant is 3.6 years, meaning people have to put their lives on standby for years as they go to three dialysis appointments per week.
Kidney disease is a big, intractable problem, so it requires a multidisciplinary approach. That’s why McMahon teamed up with Carl Kesselman, study co-author and Dean’s Professor of Industrial and Systems Engineering at USC Viterbi.
Kesselman and his team at the Information Sciences Institute at USC Viterbi built software that automated many of the tasks researchers needed to perform, such as recording data observed by a high-resolution microscope. The tool not only fast-tracked one of the three studies but also created an online, searchable library to help other stem cell scientists in their kidney disease research.
“If you think of data as the modern version of a book, we gave the researcher tools to write the book, made the library where the book is stored and created a catalog system so others can find the book and check it out,” said Kesselman, a principal investigator at the USC Michelson Center for Convergent Bioscience.
To achieve this, Kesselman’s team created DERIVA (Discovery Environment for Relational Information and Versioned Assets), a software program that collected data from microscopes and organized them and other study data into virtual photo albums that easily can be shared with other researchers.
“It’s the difference between taking a photo with film or taking it with your smartphone and using the metadata that is automatically generated to organize your photos,” Kesselman said. “At some point, you have so many photos that they become unmanageable. You can’t find the one you want. DERIVA automatically catalogs your data so you can analyze massive amounts of data with Zen-like calm and share them with all of your friends throughout the world.”
Jill McMahon, Jinjin Guo, Tracy Tran, Qiuyu Guo, Elisabeth Rutledge, Riana Parvez, Gohar Saribekyan, Christopher Liao, Albert Kim, Ahmed Abdelhalim, Seth Ruffins and Andrew Ransick from the Department of Stem Cell Biology and Regenerative Medicine at the Keck School of Medicine; Robert Schuler from the Information Sciences Institute at USC Viterbi; Matthew Thornton, Brendan Grubbs, Guilherme De Sena Brandine and Andrew D. Smith from USC; and Laurence Basking from the University of California, San Francisco also contributed to this study.
The research was supported by the California Institute for Regenerative Medicine (CIRM LA1-06536), National Institutes of Health (NIH DK107350, DK094526, DK110792, 5F32DK109616-02), National Institute of Diabetes and Digestive and Kidney Diseases (F31DK107216, 1U24DK110814) and Joint Medical/Research Council/Wellcome Trust (099175/Z/12/Z) as well as by a USC Stem Cell Hearst Fellowship and a USC Research Enhancement Fellowship.
About USC Stem Cell
USC Stem Cell is a collaborative, multidisciplinary effort working to translate the potential of stem cell research to the clinical imperative of regenerative medicine. Centered at the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, the initiative brings together nearly 100 research and clinical faculty members from the Keck School of Medicine of USC, Children’s Hospital of Los Angeles, the USC Viterbi School of Engineering, the USC Davis School of Gerontology, the Ostrow School of Dentistry of USC, the USC School of Pharmacy, and the USC Dornsife College of Letters, Arts and Sciences.
About the USC Michelson Center for Convergent Bioscience
The USC Michelson Center for Convergent Bioscience, located in Michelson Hall, brings together a diverse network of premier scientists and engineers from the USC Dornsife College of Letters, Arts and Sciences, USC Viterbi School of Engineering and Keck School of Medicine of USC to solve some of the greatest intractable problems of the 21st century – from cancer, to neurological disease, to cardiovascular disease. With a generous $50 million gift from Gary K. Michelson, a retired orthopedic spinal surgeon, and his wife, Alya Michelson, the USC Michelson Center for Convergent Bioscience occupies the largest building on campus, a state-of-the-art facility for USC to transform and influence the course of scientific discovery and biomedicine for generations to come. Information about the USC Michelson Center for Convergent Bioscience is available at https://michelson.usc.edu.
Gif: Video of kidney development also available on YouTube. Each human kidney contains one million mature nephrons, which form an expansive tubular network (white) that filters the blood, ensuring a constant environment for all of our body’s functions. (Courtesy of Stacy Moroz and Tracy Tran/Andy McMahon Lab, USC Stem Cell)
Image 1: Early stage of human nephron (kidney cell) development. (Courtesy of Stacy Moroz and Tracy Tran/Andy McMahon Lab, USC Stem Cell)
Image 2: A kidney organoid on Day 16 of differentiation. (Courtesy of Tracy Tran/Andy McMahon Lab, USC Stem Cell)